ClearPoint Neuro (CLPT) Net Equity Issued and Repurchased (2011 - 2025)
ClearPoint Neuro (CLPT) posted Net Equity Issued and Repurchased of $3.3 million for Q2 2025, up 9697.06% sequentially from -$34000.0 in Q4 2024, and up 19294.12% YoY from N/an in Q2 2024.
ClearPoint Neuro (CLPT) Net Equity Issued and Repurchased (2011 - 2025) Analysis & Trends
ClearPoint Neuro has reported Net Equity Issued and Repurchased for 5 years, with the latest figure at $3.3 million in Q2 2025.
- Quarterly Net Equity Issued and Repurchased rose 19294.12% year-over-year to $3.3 million in Q2 2025, while the trailing twelve-month figure through Dec 2025 was $3.3 million (down 79.79% YoY) and the FY2025 annual result came in at $3.3 million, down 79.79% from the prior year.
- Net Equity Issued and Repurchased improved to $3.3 million in Q2 2025 per CLPT's latest filing, from -$34000.0 in the prior quarter.
- Over five years, Net Equity Issued and Repurchased peaked at $46.8 million in Q1 2021 and troughed at -$34000.0 in Q4 2024.
- A 3-year average of $13.2 million and a median of $3.3 million in 2025 frame the typical range for Net Equity Issued and Repurchased.
- The widest YoY moves for Net Equity Issued and Repurchased: up 19294.12% in 2025, down 19294.12% in 2025.
- Over 3 years, Net Equity Issued and Repurchased stood at $46.8 million in 2021, then slumped by 100.07% to -$34000.0 in 2024, then soared by 9697.06% to $3.3 million in 2025.
- According to Business Quant data, Net Equity Issued and Repurchased over the past three periods registered $3.3 million, -$34000.0, and -$17000.0 for Q2 2025, Q4 2024, and Q2 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Equity Issued and Repurchased (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 198.70 Bn | 193.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 125.85 Bn | 122.37 Bn | 4.50 Bn | - |
| 3 | Medtronic | 118.44 Bn | 109.22 Bn | 6.41 Bn | 97.00 Mn |
| 4 | Boston Scientific | 72.64 Bn | 72.10 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 51.94 Bn | 47.69 Bn | 1.35 Bn | - |
| 6 | Dexcom | 34.48 Bn | 32.53 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.60 Bn | 31.49 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.30 Bn | 22.98 Bn | 4.55 Bn | - |
| 9 | Steris | 23.00 Bn | 22.52 Bn | 684.20 Mn | - |
| 10 | ClearPoint Neuro | 460.04 Mn | 430.64 Mn | 6.71 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2025 | 3.26 Mn |
| Jun 30, 2025 | 3.26 Mn |
| Dec 31, 2024 | -34,000.00 |
| Dec 31, 2024 | -34,000.00 |
| Jun 30, 2024 | -17,000.00 |
| Jun 30, 2024 | -17,000.00 |
| Mar 31, 2024 | 16.20 Mn |
| Mar 31, 2024 | 16.20 Mn |
| Mar 31, 2021 | 46.79 Mn |
| Mar 31, 2021 | 46.79 Mn |
| Dec 31, 2019 | 1,574.00 |
| Dec 31, 2019 | 1,574.00 |
| Sep 30, 2019 | 4,351.00 |
| Sep 30, 2019 | 4,351.00 |
| Dec 31, 2011 | 1.52 Mn |
| Dec 31, 2011 | 1.52 Mn |
| Sep 30, 2011 | 1.31 Mn |
| Sep 30, 2011 | 1.31 Mn |